10-Q: SelectQuote Q3 2026: Revenue Declines Amid Cost Cuts

SelectQuote reported a 15% year-over-year revenue decrease for the third quarter of 2026, driven by declines in both its Senior and Healthcare Services segments, alongside a net loss.

Summary

• SelectQuote's total revenue for the three months ended September 30, 2026, was $280.0 million, a 15% decrease from $328.8 million in the same period of 2025.
• The company reported a net loss of $20.3 million for the quarter, compared to a net loss of $30.5 million in the prior year's quarter.
• Revenue from the Senior segment decreased by 14% to $50.8 million, and Healthcare Services revenue fell by 16% to $186.3 million.
• Life segment revenue decreased by 8% to $42.8 million.
• Operating costs and expenses decreased by 17% to $308.6 million, leading to a reduced loss from operations of $28.6 million compared to $40.7 million in the prior year.
• Cash used in operating activities was $17.2 million, an improvement from $21.6 million in the prior year's quarter.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to declining revenues across key segments and a continued net loss, despite some operational cost reductions.

Positives

• Reduced net loss to $20.3 million from $30.5 million in the prior year's quarter.
• Operating costs and expenses decreased by 17% to $308.6 million.
• Marketing and advertising expenses decreased by 25% to $46.4 million.
• Cost of goods sold for pharmacy revenue decreased by 19% to $155.3 million.
• Cost of commissions and other services revenue decreased by 11% to $61.8 million.
• Adjusted EBITDA for Healthcare Services improved to $11.2 million from $7.2 million.
• Adjusted EBITDA for Life improved to $7.3 million from $5.6 million.
• The company expects existing cash, revolving credit facility, and operational cash flow to be sufficient for working capital and debt service.

Negatives

• Total revenue decreased by 15% to $280.0 million.
• Senior segment revenue decreased by 14% to $50.8 million.
• Healthcare Services segment revenue decreased by 16% to $186.3 million.
• Life segment revenue decreased by 8% to $42.8 million.
• Total submitted policies decreased by 24% compared to the prior year.
• Total approved policies decreased by 22% compared to the prior year.
• Total SelectRx members decreased by 7% to 99,753.
• Average prescriptions shipped per day decreased by 10%.

Risks

• The company is subject to legal proceedings, including securities class actions and stockholder derivative suits, which could result in significant damages and diversion of management attention.
• The company faces market risk from changes in interest rates, with a hypothetical 100 basis point increase potentially increasing annualized interest expense by approximately $3.4 million.
• The company's reliance on insurance carrier partners means that changes in their offerings or relationships could impact revenue.
• The company's business is subject to seasonality, particularly in the Senior segment due to the Medicare annual enrollment period.
• The company's ability to collect commissions receivable depends on the timing of payments from insurance carrier partners, which could impact operating cash flows.
• The company is subject to regulatory changes, such as the Inflation Reduction Act, which can affect revenue and costs (e.g., manufacturer refunds).

Future Outlook

The company expects that its existing cash, cash equivalents, funds available under the revolving credit facility, and cash provided from operations will be sufficient to finance normal working capital needs, investments in properties, facilities, and equipment, and debt services for the 12 months following the date of issuance of the financial statements. Management projects continued compliance with debt covenants.

Management Comments

• The company has increasingly focused on expanding its healthcare services platform as a natural extension of its core Senior distribution insurance business, prioritizing higher-growth opportunities such as pharmacy services.
• The company has de-emphasized production within its Auto & Home distribution insurance business.
• The company continues to leverage strategic investments in AI capabilities to improve agent productivity and reduce the cost of consumer acquisition and servicing.
• The company believes its ability to engage consumers, capture self-reported information, and offer personalized solutions is key to its value proposition.
• Management believes that none of the current legal proceedings will have a material adverse effect on its operations, financial condition, or liquidity, though they could be costly to defend.

Industry Context

StockSavvy.ai notes that SelectQuote operates in the competitive insurance distribution and healthcare services sectors. The decline in revenue and policy submissions across its core Senior and Life segments, coupled with a decrease in SelectRx members, suggests broader market pressures or execution challenges impacting customer acquisition and retention within these areas. The company's strategic shift towards healthcare services, while showing some positive Adjusted EBITDA, is not yet sufficient to offset declines in its traditional insurance distribution businesses.

Comparison to Industry Standards

• The decline in submitted and approved policies (24% and 22% respectively) in the Senior segment is a significant negative trend compared to industry peers who may be experiencing more stable or growing Medicare Advantage enrollment.
• The 7% decrease in SelectRx members and 10% decrease in prescriptions per day in the Healthcare Services segment indicates a potential underperformance relative to the growing demand for pharmacy and chronic care management services.
• The 16% increase in LTV per Medicare Advantage approved policy is a positive indicator, suggesting improved pricing or carrier mix, but it does not offset the overall volume decline.
• The company's marketing and advertising spend reduction of 25% may be a necessary cost-saving measure but could hinder future lead generation and customer acquisition compared to competitors who maintain or increase marketing investments.

Legal Proceedings

• Securities Class Action (Hartel Action, WPBPPF Action, consolidated as In re SelectQuote, Inc. Securities Litigation): Allegations of securities fraud and misstatements related to the company's business and prospects. The appeal is pending before the Second Circuit.
• Stockholder Derivative Action (Jadlow Action): Allegations against directors and officers for violations of Section 14(a) and breach of fiduciary duty. The action remains stayed.
• DOJ Action (United States ex rel. Shea v. eHealth, Inc., et al.): Allegations of violations of the Federal False Claims Act by the company and competitors related to sales and marketing practices. The court denied motions to dismiss on most counts.
• Securities Class Action (Pahlkotter Action): Allegations of securities law violations related to the DOJ Action. The action is stayed pending the filing of an amended complaint.
• Stockholder Derivative Actions (Scotto Action, Kelly Action): Allegations against directors and officers for violations of Section 14(a) and breach of fiduciary duty related to the DOJ Action. Consolidated and stayed pending resolution of the Pahlkotter Action.

Related Party Transactions

• No material related-party transactions were disclosed for the three months ended September 30, 2026.
• No outstanding balances were due to or from related parties as of September 30, 2026.

Stakeholder Impact

• Shareholders: Continued net losses and declining revenues may negatively impact share price and investor confidence. The ongoing legal proceedings also present a risk.
• Creditors: The company's debt obligations and covenant compliance are critical. While management expects to remain compliant, significant downturns could pose risks.
• Employees: Reductions in marketing and headcount in certain areas may impact employment levels. Investments in AI aim to improve agent productivity.
• Customers: The company's focus on personalized solutions and improved customer experience aims to enhance retention. However, declines in service volume could affect customer engagement.

Next Steps

• Continue to leverage AI capabilities for agent productivity and cost reduction.
• Focus on delivering comprehensive and personalized healthcare solutions.
• Monitor compliance with debt covenants and manage liquidity.
• Continue to defend against ongoing legal proceedings.

Key Dates

Recommendation

The persistent decline in revenue across key segments, coupled with ongoing net losses and significant legal risks, suggests a deteriorating financial position. While cost-saving measures are being implemented, they have not yet translated into top-line growth or profitability. The negative operational trends and substantial legal liabilities warrant a cautious approach.

Keywords

SelectQuote, Medicare Advantage, Senior Health Insurance, Pharmacy Services, Life Insurance, Revenue, Net Loss, Adjusted EBITDA